Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy

NCT01140867 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.

NCT NCT01140867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01140867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy
Lead sponsor
Eisai Korea Inc.
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2008
Completion date
March 31, 2011
Enrollment
121 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy